DIAGNOSTIC IMAGING OF DISORDERS OF SEX DEVELOPMENT (DSD) IN INFANTS AND CHILDREN-Reference-Cited by-同舟云学术

DIAGNOSTIC IMAGING OF DISORDERS OF SEX DEVELOPMENT (DSD) IN INFANTS AND CHILDREN

Published:2022-09-01 Issue: Volume: Page:24-27
ISSN:
Container-title:INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
language:en
Short-container-title:ijsr

Author:

Al Jurayyan Rushid N.A.¹,Al Jurayyan Abdulrahman N.A.²,Al Omran Hanan I.O.³,Al Jurayyan Nasir A.M.⁴

Affiliation:

1. M.D Assistant professor, and Head, Department of Radiology and Medical Imaging, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

2. MBBS Radiology Resident, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

3. M.D, Assistant professor, and Consultant, Department of pediatrics, Prince Sattam University, Alkharj, Saudi Arabia.

4. M.D Professor and consultant (Retired), King Saud University, Riyadh, Saudi Arabia.

Abstract

Various disorders of sex development (DSD), result in an abnormal development of genitalia formerly known as ambiguous genitalia or intersex disorders. It Is a complex social and medical emergency. The participation of a multidisciplinary team, including a pediatric radiologist, is needed to address the patient's medical need. The rst step in the management of DSD is to assign the sex of rearing, which should be based on multiple factors, such as genotype, the presence, location and appearance of the reproductive organs. various modalities of radiological imaging are used and shown to be of value in diagnosis. Ultrasound (US) is the primary tool for demonstrating internal organs, while genitography is used to assess the uterus, vagina and any stulas or Complex tracts. Magnetic resonance imaging (MRI) may provide additional and accurate information about the internal gonads and genitalia

Publisher

World Wide Journals

Subject

Water Science and Technology,History,Cultural Studies,Cancer Research,Oncology,Cancer Research,Oncology,Cancer Research,Pharmacology,Oncology,Molecular Medicine,Cancer Research,Genetics,Oncology,General Medicine,Cancer Research,Pharmacology,Cancer Research,Oncology,Cancer Research,Genetics,Oncology,Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Reference24 articles.

1. Ahmed SF, Achermann JC, Arlt W, Balen A, Conway G, Edwards Z, et al. Society for Endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (Revised 2015). Clin Endocrinol (Oxf). 2016;84(5):771- 88.

2. Hiort O, Birnbaum W, Marshall L, Wünsch L, Werner R, Schröder T, et al. Management of disorders of sex development. Nat Rev Endocrinol. 2014;10(9):520-9.

3. Houk CP, Lee PA. Update on disorders of sex development. Current Opinion in Endocrinology, Diabetes and Obesity. 2012;19(1):28-32.

4. Moshiri M, Chapman T, Fechner PY, Dubinsky TJ, Shnorhavorian M, Osman S, et al. Evaluation and management of disorders of sex development: multidisciplinary approach to a complex diagnosis. Radiographics. 2012;32(6):1599-618.

5. Cools M, Nordenström A, Robeva R, Hall J, Westerveld P, Flück C, et al. Caring for individuals with a difference of sex development (DSD): a Consensus Statement. Nat Rev Endocrinol. 2018;14(7):415-29.